Back

The Association of Kawasaki Disease and COVID-19 with Cardiac Complications:

The Association of Kawasaki Disease and COVID-19 with Cardiac Complications: A Focused Sub-study of the International Kawasaki Disease Registry (IKDR)

  • Clinical Trial Information

    Trial Contact: Beltran, Yajira

    Trial Phone: 321.841.7619

  • IRB No: 20.112.07

    Protocol Abbrev: IKDR

    Principal Investigator: Federico Ricardo Laham, MD

    Age Group: Pediatric

  • Objective

    1. To determine the spectrum of cardiac complications, associated factors and outcomes in patients with Pediatric Multi-system Inflammatory Syndrome associated with COVID-19.
    2. To determine the incidence and epidemiology of KD, particularly those with missed or delayed diagnosis, and the spectrum of cardiac complications, associated factors and outcomes during the COVID-19 pandemic.
    3. To determine the prevalence and spectrum of cardiac complications in pediatric patients with documented or presumed infection with COVID-19, together with associated factors and outcomes.

  • Key Eligibility

    Outpatient assessment or inpatient admission to a participating site starting January 1,
    2020.
    Any of:
    1. Patients for whom there has been a request for echocardiography or pediatric cardiology consultation for evaluation and the patient has or has had confirmed or suspected COVID-19 infection.
    2. Patients with a confirmed or suspected diagnosis of complete or incomplete KD, or KD shock syndrome.
    3. Patients with confirmed or suspected Pediatric Multi-system Inflammatory Syndrome (PMIS) associated with or assumed to be associated with COVID-19.